Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide
and is associated with high case fatality rates and serious life-long complications among …

Meningococcal disease remains an important cause of morbidity and death worldwide
despite the development and increasing implementation of effective vaccines. Elimination of …

Background 4CMenB is a protein-based meningococcal B vaccine, but the vaccine antigens
may be present on non–group B meningococci. In September 2015, the UK implemented …

Introduction Social deprivation is associated with poorer healthcare access. Vaccination is
among the most effective public health interventions and achieving equity in vaccination …

Background Invasive meningococcal disease (IMD) epidemiology has fluctuated over the
past 25 years and varies among serogroups, age groups and geographical locations. Aim …

Invasive meningococcal disease (IMD) is a life-threatening, unpredictable condition.
Vaccines are available against 5 of the 6 meningococcal serogroups (Men) accounting for …

Background The multicomponent meningococcal serogroup B vaccine (4CMenB) is
currently indicated for active immunization against invasive meningococcal disease caused …

Background In response to the recent serogroup W invasive meningococcal disease (IMD-
W) epidemic in the Netherlands, meningococcal serogroup C (MenC) conjugate vaccination …

Neisseria meningitidis, carried in the human nasopharynx asymptomatically by~ 10% of the
population, remains a leading cause of meningitis and rapidly fatal sepsis, usually in …

This narrative review describes the public health importance of four most common bacterial
meningitis agents, Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus …